The January/February edition of The Nation Psychologist reported that The American Psychological Association is “leading the charge” against attempts to further medicalize the new Diagnostic and Statistical Manual (DMS-IV) due to be published in May of 2013.
Among the major concerns about the new revision are: (1) unwarranted expansion of diagnostic categories by reducing current thresholds and added untested diagnoses (2) pathologizing “natural and normal” responses to life experiences. Concerns that “natural and normal” behaviors will be diagnostically labeled, have been around a long time and have lead to things like pregnancy being called a disease. (3) imposing dimensional diagnoses that are far too cumbersome and complex for clinical use, and (4) a push to see all mental disorders as biological phenomena calling for psychotropic medications.
Thousand of professionals have signed a petition calling attention to these concerns that was started by the Society for Humanistic Psychology (APA Division 32). Long time national DSM leader, psychiatrist Allen Frances, M.D. has been especially vocal in his criticism of many of the new proposals.
According to James Bradshaw, a senior editor at The National Psychologist even the highly conservative CATO Institute think tank is opposed to lowering diagnostic thresholds, since that might result in thousands of claims against employers, under workers compensation laws, the ADA or FMLA.
Ironically there are also concerns about DSM-V raising some diagnostic thresholds. New York Times reporter Benedict Carey, says that proposed changes in the definition of autism would greatly reduce the number of people diagnosed and make it much more difficult for many of them get the services they need.
Analyzing data from a large 1993 study researchers Fred Volkmar, Brian Reichow, and James McPartland, (all from Yale) found that among the 372 highest functioning children and adults in the study only 45 percent would met the new criteria for autism spectrum diagnosis. Among the highest functioning individuals, the analysis suggested that about 25% of people diagnosed with classic autism in 1993 would be excluded, along with about 85 % of those with P.D.D.-N.O.S.
Volkmar, director of the Child Study Center at the Yale School of Medicine, says, “The changes would narrow the diagnosis so much that it could effectively end the autism surge”.
Catherine Lord, director of the Institute for Brain Development and a member of the DSM-V task force working on the diagnosis, strongly disagrees with these projections, citing the focus on higher functioners and the use of old data as possible reasons for the exaggerated numbers.
Of course the DSM’s clinical utility has long since been compromised by its use, both as a billing and an eligibility criteria for benefits and services.